AzTrials
AzTrials

Patient ComplianceNCT07555262

Reminder Strategies to Improve Meal-Logging Adherence

A study testing Loss-Framed Reminder, Logging Consistency Reminder and Neutral Reminder in people with Patient Compliance and Mobile Applications, run by University of St.Gallen at 1 site in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study is a single-center micro-randomized trial, aiming to examine the effects of two theory-driven reminder strategies on adherence to repeated, image-based meal logging in adults age 45 and older. Read more about this study

Who is it for?
Ages 45 years and olderHealthy volunteers can take part
What is being tested?
Loss-Framed Reminder, Logging Consistency Reminder and Neutral Reminder
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteSwitzerland
Study dates
8 Dec 2025to Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Citizens or residents of Switzerland who are German-speaking (main place of living or employment in Switzerland).
  • Age ≥45 years.
  • BMI ≥25 kg/m² (overweight or obese).
  • Regular access to a smartphone (iOS or Android) with a data plan.
  • Able to use smartphone applications.
  • Able to walk independently.

Who cannot join

  • History of stroke, heart disease, renal failure, cancer, or diabetes (type 1 or type 2).
  • Past vascular bypass surgery or angioplasty.
  • Current or planned use of glucose-lowering medications during the upcoming 4 weeks (e.g., GLP-1 receptor agonists, metformin).
  • Pregnant or breastfeeding.
  • Relevant skin conditions at wearable placement sites (e.g., upper arm).
  • BMI <25 kg/m² confirmed at enrollment.
  • FPG ≥7.0 mmol/L and/or HbA1c ≥6.5% (newly identified type 2 diabetes); Individuals who meet type-2 diabetes criteria at enrollment, based on Swiss/ADA diagnostic criteria will be informed of blood test results and referred to a GP. These individuals will be deemed ineligible and excluded from the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mia Jovanova, Dr. contact

+41 44 632 05 41

mia.jovanova@unisg.ch

Switzerland1 site, 1 recruiting
  • HOCH Health and School of Medicine, University of St. Gallen

    Sankt Gallen, Canton of St. Gallen, 9000

    Mia Jovanova, Dr., +41 44 632 05 41, mia.jovanova@unisg.ch

    Tobias Kowatsch, Prof.Dr.

    Recruiting

Other trials in Switzerland

About this study

This study is a single-center micro-randomized trial, aiming to examine the effects of two theory-driven reminder strategies on adherence to repeated, image-based meal logging in adults age 45 and older. Three times daily, participants are automatically randomized to receive one of three reminder messages prior to each habitual mealtime. The main research questions the trial aims to answer are:

  • Do loss-framed reminders (emphasizing loss of a daily financial reward for not logging) increase meal logging adherence in the two hours following a reminder, compared to a neutral reminder?
  • Do logging consistency reminders (providing feedback on recent logging streaks) increase meal logging adherence in the two hours following a reminder, compared to a neutral reminder?
  • Do the effects of loss-framed and logging consistency reminders differ from each other?
Read more

Primary aim: To estimate the proximal effect of each reminder type on whether a participant logs a meal within two hours of receiving a reminder.

Secondary aim: To examine whether within-person physiological patterns (e.g., heart rate variation) moderate response to reminders, with the goal of identifying physiological markers of receptivity to behavioral prompts.

The trial aims to enroll 200 adults aged 45 and older. Participants attend a baseline visit for onboarding, consent, and device setup, followed by a 28 day remote intervention period during which they should photograph their meals three times daily (breakfast, lunch, dinner) and wear a smartwatch and smart ring continuously. Prior to each mealtime, they receive an automatically randomized reminder message. Participants earn a daily financial reward contingent on completing meal logging for that day.

Note: This trial was registered retrospectively as enrollment began prior to registration. However, registration was completed before data collection was finished and before any data analysis was conducted.

Being tested
Loss-Framed Reminder, Logging Consistency Reminder, Neutral Reminder
Keywords
micro-randomized trial, adherence
Medical subject headings
Patient Compliance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Loss-Framed ReminderBehavioural

    Push notification emphasizing loss of daily financial reward for not logging the upcoming meal.

  • Logging Consistency ReminderBehavioural

    Push notification providing feedback on recent meal logging streak.

  • Neutral ReminderBehavioural

    Push notification reminding participants to log a meal.

Study groups in NCT07555262
Study groupRoleWhat they receive
Loss-Framed ReminderExperimentalA push notification emphasizing the loss of a daily financial reward for not logging the upcoming meal. Assigned with 1/3 probability at each decision point.
Receives: Behavioral: Loss-Framed Reminder
Logging Consistency ReminderExperimentalA push notification providing feedback on the participant's recent meal logging streak. Assigned with 1/3 probability at each decision point.
Receives: Behavioral: Logging Consistency Reminder
Neutral Reminder (Active Control)Active comparatorA push notification reminding the participant to log a meal without loss-framing or consistency feedback. Serves as the reference condition against which the two experimental reminders are compared. Assigned with 1/3 probability at each decision point.
Receives: Behavioral: Neutral Reminder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Meal Logging Adherence

    Proportion of decision points at which a participant logs a meal within 2 hours of receiving a reminder, compared across reminder types (loss-framed, logging consistency, and neutral control).

    Measured: Within 2 hours of each decision point, assessed over 28 days

Secondary outcomes (1)
  1. Moderators of Reminder Responsiveness

    Meal logging adherence (binary, within 2 hours of a decision point) examined as a function of participant-level moderators including physiological (e.g., heart rate variability), demographic (e.g., age, sex), and behavioral characteristics, to identify moderators of differential responsiveness to reminder types.

    Measured: Assessed over 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2026
  2. Study start8 Dec 2025
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Sequential
Model description
Micro-randomized trial (MRT). Participants are randomized independently at each decision point (prior to each of 3 daily mealtimes) over 28 days, resulting in up to 84 randomizations per participant. At each decision point, participants are assigned with equal probability to one of three reminder conditions: loss-framed, logging consistency, or neutral control.
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07555262
Sponsor's protocol ID
GLOWUP-MRT
Status last verified
Apr 2026
First submitted
21 Apr 2026
Last updated
5 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Loss-Framed Reminder, Logging Consistency Reminder and Neutral Reminder in people with Patient Compliance and Mobile Applications, run by University of St.Gallen at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mia Jovanova, Dr. (+41 44 632 05 41, mia.jovanova@unisg.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Meal Logging Adherence (time frame: Within 2 hours of each decision point, assessed over 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in